ER expression in the primary tumor, as determined by IHC, was significantly decreased in mice treated with ICI (a selective estrogen receptor degrader) compared with the ER+ tumors without treatment (p < 0.05, Mann–Whitney Test; Supplemental Figure S4). Here, ESR1 is linked to neoplasm.